Marleen Schoonen

Marleen Schoonen is a seasoned business professional with a robust background in the healthcare industry, specializing in clinical evidence generation and product development for medical devices. Marleen previously served as the Director of Corporate Communication & Corporate Initiatives at Polyganics and is currently the Director of Clinical Affairs at Philips, where they lead clinical evidence strategy for diagnostic programs. With extensive experience as a Medical Advisor at Novo Nordisk and UCB Pharma, Marleen has demonstrated a strong ability to facilitate scientific knowledge exchange and develop strategic narratives in complex environments. Marleen holds a Master of Science in Psychology from Universiteit van Tilburg and an MSc in Public Health from Erasmus University Rotterdam.